Latest News

Management of Asthma in Different Phenotypes – Presented at APSR 2019

Management of Asthma in Different Phenotypes – Presented at APSR 2019

Professor David Price recently spoke about the management of asthma in different phenotypes at the Asian Pacific Society of Respirology’s Asthma Symposium 2019. While...

Read more
Inhaled Corticosteroids In COPD And Onset Of Type 2 Diabetes And Osteoporosis: A Matched Cohort Study

Inhaled Corticosteroids In COPD And Onset Of Type 2 Diabetes And Osteoporosis: A Matched Cohort Study

A study by OPRI published in NPJ Primary Care Respiratory Medicine found a link between ICS therapy for patients with COPD and the onset of type 2 diabetes and...

Read more
Describing the GOLD Group Distribution and Appropriateness of Therapy in Patients with COPD.

Describing the GOLD Group Distribution and Appropriateness of Therapy in Patients with COPD.

A study by OPRI describing in details the GOLD group distribution in patients with COPD who started their initial treatment and those with established COPD has been...

Read more
Leveraging Randomized Clinical Trials to Generate Real-World Evidence for Regulatory Purposes

Leveraging Randomized Clinical Trials to Generate Real-World Evidence for Regulatory Purposes

Washington, 11th July 2019 – Professor David Price, head of The Observational & Pragmatic Research Institute (OPRI; Singapore) and Optimum Patient Care (OPC...

Read more
Management of Community-Acquired Pneumonia: An Observational Study in UK Primary Care

Management of Community-Acquired Pneumonia: An Observational Study in UK Primary Care

A study to assess the frequency of CRB65 scoring in patients diagnosed with community-acquired pneumonia (CAP) in primary care has been recently published in the Dove...

Read more
Omalizumab in the Era of Precision Medicine

Omalizumab in the Era of Precision Medicine

Allergic allergy has been increasing in Hong Kong given evolutionary and genetic or environmental factors. Omalizumab, or anti-IgE, is a monoclonal antibody approved...

Read more
Primary Care Respiratory Society Conference 2019 🗓

Primary Care Respiratory Society Conference 2019 🗓

The PCRS Respiratory Conference is the UK’s leading respiratory conference. Its aim is to inspire delegates to discover new ways of working with patients and...

Read more
Boehringer Ingelheim and Optimum Patient Care Launch First US Primary Care Patient Registry to Improve COPD Care and Outcomes

Boehringer Ingelheim and Optimum Patient Care Launch First US Primary Care Patient Registry to Improve COPD Care and Outcomes

First-of-its-kind registry to exclusively focus on chronic obstructive pulmonary disease (COPD) treatment by primary care physicians    Registry will track 3,000...

Read more
Could heart drug help lung disease patients?

Could heart drug help lung disease patients?

Drugs traditionally used to treat blood pressure and heart disease are to be given to lung disease patients to see if they can be beneficial, in a trial coordinated...

Read more
Adding low dose theophylline to inhaled corticosteroids does not reduce COPD exacerbations

Adding low dose theophylline to inhaled corticosteroids does not reduce COPD exacerbations

A CRN supported Respiratory Disorders trial (TWICS), which investigated whether taking a low-dose theophylline tablets in addition to inhaled corticosteroids would...

Read more
Does changing inhaler device change asthma outcomes?

Does changing inhaler device change asthma outcomes?

Singapore, 5th October 2018. Most people with asthma rely on inhaled asthma medication to control their symptoms. Inhaler devices are available as either dry powder...

Read more
Predictive utility of database-derived asthma exacerbation and asthma control measures in a UK primary care database

Predictive utility of database-derived asthma exacerbation and asthma control measures in a UK primary care database

Database-derived measures of asthma control was predictive of asthma treatment response and future asthma exacerbation. This study validates the usage of database...

Read more
COPD patient subset gains no benefit from low-dose theophylline

COPD patient subset gains no benefit from low-dose theophylline

AT ATS 2018 SAN DIEGO – For people with COPD at high risk of exacerbation, the addition of low-dose theophylline to inhaled corticosteroids conferred no overall...

Read more
Hay fever sufferers may not be picking the right drugs to treat symptoms

Hay fever sufferers may not be picking the right drugs to treat symptoms

A study in The Journal of Allergy and Clinical Immunology: In Practice found the majority of surveyed people with hay fever were not picking optimal over-the-counter...

Read more
Breathing exercises help asthma patients with quality of life

Breathing exercises help asthma patients with quality of life

Southampton, 12th December, 2017. A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving...

Read more
REcognise Asthma and LInk to Symptoms and Experiences (REALISE)

REcognise Asthma and LInk to Symptoms and Experiences (REALISE)

REALISE survey aimed to assess levels of asthma control and patient-reported asthma control Factor analysis identified distinct patient clusters with varying...

Read more
Blood eosinophil counts help predict COPD exacerbation risk in ex-smokers

Blood eosinophil counts help predict COPD exacerbation risk in ex-smokers

Singapore, 13th November, 2017. Chronic obstructive pulmonary disease (COPD) is an important public health challenge as it is a major cause of chronic morbidity and...

Read more
Nicotine replacement therapy causes an increase in cardiovascular events during a 52-week follow-up period

Nicotine replacement therapy causes an increase in cardiovascular events during a 52-week follow-up period

Treatment with NRT during a brief, 4-week, follow-up period does not appear to put patients at risk of cardiovascular disease.  However, at 52 weeks, there was an...

Read more
To fine or extrafine: which ICS formulation has the better dose response in patients with asthma?

To fine or extrafine: which ICS formulation has the better dose response in patients with asthma?

Dose-dependent reduction in asthma exacerbations for patients treated with extrafine-particle inhaled corticosteroids in an adult UK asthma population; a result not...

Read more
International study highlights importance of inhaler technique on asthma patient outcomes

International study highlights importance of inhaler technique on asthma patient outcomes

International CRITIKAL Study1 is one of the largest to investigate inhaler technique and the first to analyse the direct associations between specific inhaler errors...

Read more